erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the
.
.
5 / 5
.
. it also provides 85 per cent accurate prediction results than current methods.
. we have let patients down, admits senior northern ireland civil servant